|
|
Volumn 508, Issue 3, 2001, Pages 365-368
|
|
Non-steroidal anti-inflammatory drugs inhibit matrix metalloproteinase-2 expression via repression of transcription in lung cancer cells
a
a
a
|
|
Author keywords
Cyclooxygenase 2; Lung cancer; Matrix metalloproteinase 2; NS398; Promoter
|
|
Indexed keywords
CYCLOOXYGENASE 2 INHIBITOR;
GELATINASE A;
GELATINASE B;
INDOMETACIN;
MESSENGER RNA;
N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE;
NONSTEROID ANTIINFLAMMATORY AGENT;
PROSTAGLANDIN E2;
ARTICLE;
CANCER CELL;
CONTROLLED STUDY;
DRUG ACTIVITY;
DRUG EFFECT;
ENZYME ACTIVITY;
ENZYME DEGRADATION;
ENZYME INHIBITION;
ENZYME REPRESSION;
ENZYME SYNTHESIS;
GENETIC TRANSCRIPTION;
HUMAN;
HUMAN CELL;
LUNG CARCINOMA;
METASTASIS;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
WESTERN BLOTTING;
ZYMOGRAPHY;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
CULTURE MEDIA, CONDITIONED;
CYCLOOXYGENASE INHIBITORS;
DINOPROSTONE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
GENE EXPRESSION REGULATION, ENZYMOLOGIC;
HUMANS;
LUNG NEOPLASMS;
MATRIX METALLOPROTEINASE 2;
MATRIX METALLOPROTEINASE 9;
NITROBENZENES;
PROMOTER REGIONS (GENETICS);
REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;
SULFONAMIDES;
TRANSCRIPTION, GENETIC;
TRANSFECTION;
TUMOR CELLS, CULTURED;
|
|
EID: 0035941141
PISSN: 00145793
EISSN: None
Source Type: Journal
DOI: 10.1016/S0014-5793(01)03118-0 Document Type: Article |
|
Times cited : (70)
|
|
References (30)
|
